Compare Amazon.com Inc (AMZN) vs Danaher Corporation (DHR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amazon.com Inc vs Danaher Corporation — how do they compare? Amazon.com Inc trades at $247.1 (market cap $2.64T), while Danaher Corporation trades at $200.14 (market cap $140.88B). The key difference: Amazon.com Inc is far larger — about 18.7× Danaher Corporation's market cap, and Danaher Corporation pays a 0.8% dividend while Amazon.com Inc pays none. Which is the better fit depends on your goals.
| AMZN | DHR | |
|---|---|---|
Market Cap | $2.64T | $140.88B |
Volume | 3,931,282 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $274.95 | $242.05 |
52-Week Low | $198.79 | $161.91 |
Enterprise Value | $2.71T | $153.66B |
Dividend Yield | — | 0.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Amazon (AMZN) trades at $247.31, up 0.8% today, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with revenue growth from $638.0B in 2024 to $716.9B in 2025 and net income rising to $77.7B. Recent news highlights CEO Andy Jassy's optimistic outlook on AWS and AI chip growth, fueling investor confidence.
Outlook remains positive with a consensus price target of $320.75, implying 30% upside. Key risks include intense competition in retail and cloud, high capital expenditures, and macroeconomic pressures. Analysts are overwhelmingly bullish (88.3% buy ratings), viewing Amazon's profit expansion and AI investments as long-term catalysts.
Danaher (DHR) trades at $199.05, up 1.57% on the day, with a bullish technical signal and strong analyst support. The stock has beaten earnings estimates for three consecutive quarters, though revenue growth remains modest and profit margins have compressed from pandemic peaks. Recent business developments include the shareholder approval of the Masimo acquisition and new product launches in its SCIEX division, suggesting ongoing strategic investment.
The outlook is cautiously optimistic, supported by a dominant 'Buy' analyst consensus and a price target implying ~7% upside. Key opportunities lie in the firm's biotechnology segment strength and strategic M&A. Risks include ongoing margin pressure, integration challenges from acquisitions, and a relatively high valuation (P/E of 38.6) that demands sustained earnings growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amazon.com Inc
Amazon.com, Inc. is an online retailer that offers a wide range of products. The Company products include books, music, computers, electronics and numerous other products. Amazon offers personalized shopping services, Web-based credit card payment, and direct shipping to customers. Amazon also operates a cloud platform offering services globally.
Read more on AMZN →About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →
